Heron Therapeutics, Inc. - Common Stock — Liquidità (NASDAQ:HRTX) | MetaTrader

Apri il grafico completo Full chart

Financials

Panoramica Estratto Conto Statistiche

Trimestrale Annuale

Flusso di cassa derivante dalle attività operative -184.82 M-203.35 M-146.91 M-58.79 M-22.53 M-27.59 M -20.26 M Flussi di cassa derivanti dalle attività di investimento 208.96 M32.73 M-3.32 M18 M18.71 M16.01 M 12.8 M Liquidità derivante dalle attività di finanziamento 9.11 M156.03 M75.06 M54.11 M940 K14.43 M 14.31 M Liquidità libera -184.82 M-203.35 M-146.91 M-58.79 M-22.53 M-27.91 M -20.86 M

Notizie

H.C. Wainwright taglia il target su Heron Therapeutics dopo i deboli risultati del Q1

Heron Therapeutics (HRTX) Reports Q1 Earnings: What Key Metrics Have to Say

Heron Therapeutics (HRTX) Reports Q1 Loss, Lags Revenue Estimates

Gli EPS di Heron Therapeuti hanno mancato le aspettative per 0,02$, il fatturato appena sotto le previsioni

Ironwood Pharmaceuticals (IRWD) Tops Q1 Earnings and Revenue Estimates

electroCore, Inc. (ECOR) Reports Q1 Loss, Beats Revenue Estimates

Earnings Preview: ARS Pharmaceuticals, Inc. (SPRY) Q1 Earnings Expected to Decline

Analysts Estimate Heron Therapeutics (HRTX) to Report a Decline in Earnings: What to Look Out for

How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings

How to Find Strong Medical Stocks Slated for Positive Earnings Surprises

Heron Therapeutics, Inc. (HRTX) Q4 2025 Earnings Call Transcript

Heron Therapeutics (HRTX) Reports Q4 Earnings: What Key Metrics Have to Say